Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(14%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
1
14%
Ph phase_2
2
29%
Ph phase_1
2
29%
Ph not_applicable
1
14%

Phase Distribution

2

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
2(33.3%)
Phase 2Efficacy & side effects
2(33.3%)
Phase 3Large-scale testing
1(16.7%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(4)
Completed(2)
Terminated(1)

Detailed Status

Not yet recruiting3
Completed2
Active, not recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (33.3%)
Phase 22 (33.3%)
Phase 31 (16.7%)
N/A1 (16.7%)

Trials by Status

active_not_recruiting114%
not_yet_recruiting343%
withdrawn114%
completed229%

Recent Activity

1 active trials
Showing 5 of 7
not_yet_recruitingphase_3

A Study to Evaluate the Immune Response and Safety of a Vaccine Against Influenza in Adults 18-64 Years of Age

NCT07851246
completedphase_2

A Study to Evaluate the Immune Response and Safety of an Influenza Vaccine in Adults 18 Years of Age and Above

NCT07204964
completedphase_2

A Study to Assess the Immune Response and Safety of a Vaccine Against Influenza in Adults 18 Years of Age and Older

NCT07121192
active_not_recruitingnot_applicable

Financial Incentives to Encourage Uptake of Preventive Dental Care Services Among Adults

NCT07083453
not_yet_recruitingphase_1

A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults: Fed State Study

NCT07044765
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT07851246Phase 3

A Study to Evaluate the Immune Response and Safety of a Vaccine Against Influenza in Adults 18-64 Years of Age

Not Yet Recruiting
NCT07204964Phase 2

A Study to Evaluate the Immune Response and Safety of an Influenza Vaccine in Adults 18 Years of Age and Above

Completed
NCT07121192Phase 2

A Study to Assess the Immune Response and Safety of a Vaccine Against Influenza in Adults 18 Years of Age and Older

Completed
NCT07083453Not Applicable

Financial Incentives to Encourage Uptake of Preventive Dental Care Services Among Adults

Active Not Recruiting
NCT07044765Phase 1

A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults: Fed State Study

Not Yet Recruiting
NCT07034781Phase 1

A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults

Not Yet Recruiting
NCT04799990

Study to Assess Adverse Events When Subcutaneous Risankizumab Injection is Given to Adult Participants With Psoriasis in Real World Setting

Withdrawn

All 7 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
7